GlaxoSmithKline PLC shareholders have backed the company over concerns that activist U.S. hedge fund Elliott Management is set to push for a shakeup, The Times reports.
--Several top 20 shareholders in the British pharmaceutical company have contacted Chairman Jonathan Symonds to express support for the board and its current strategy, according to The Times.
--Elliott hasn't yet revealed its intentions to the company but has begun to engage with other leading shareholders, The Times reports.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.